| Title[sort] |
Cycle |
Award[sort] |
| Treating BC Brain Metastases with Cytotoxic Lymphocytes |
2008 (Cycle 14) |
$186,496 |
| Investigator(s): Barbara Mueller , Ph.D. |
14IB-0045 |
| Global Analysis of Protein Ubiquitination in Breast Cancer |
2008 (Cycle 14) |
$45,000 |
| Investigator(s): Stefan Grotegut , Ph.D. |
14FB-0114 |
| Vascular Targeting Therapy for Breast Cancer |
2006 (Cycle 12) |
$288,728 |
| Investigator(s): Albert Deisseroth , M.D., Ph.D. |
12IB-0159 |
| Identification of Metastasis Competent Breast Cancer Cells |
2006 (Cycle 12) |
$59,805 |
| Investigator(s): Barbara Mueller , Ph.D. |
12IB-0096A |
| Her-2/neu-Crosreactive Analogs as Targets for Breast Cancer |
2004 (Cycle 10) |
$371,110 |
| Investigator(s): Joseph Lustgarten , Ph.D. |
10WB-0010 |
| Glycoconjugates: Novel Non-toxic Therapies for Breast Cancer |
2003 (Cycle IX) |
$191,278 |
| Investigator(s): Margaret Huflejt , Ph.D. |
9IB-0032 |
| Cryptic Peptides-Based Vaccines for Breast Tumor Treatment |
2003 (Cycle IX) |
$371,110 |
| Investigator(s): Joseph Lustgarten , Ph.D. |
9WB-0100 |
| Retinoids in Combination Therapies against Breast Cancer |
2002 (Cycle VIII) |
$389,000 |
| Investigator(s): F. Javier Piedrafita , Ph.D. |
8WB-0065 |
| Identifying Accessible Targets in Human Breast Tumors |
2002 (Cycle VIII) |
$480,843 |
| Investigator(s): Jan Schnitzer , M.D. |
8WB-0113 |
| Targeting of Tumor-Promoting Galectins in Breast Cancer |
2001 (Cycle VII) |
$182,500 |
| Investigator(s): Margaret Huflejt , Ph.D. |
7IB-0039 |
| Role of p14ARF in Metastatic Breast Cancer |
2000 (Cycle VI) |
$365,000 |
| Investigator(s): Ruth Gjerset , Ph.D. |
6JB-0077 |
| A Novel Antigen Associated with Breast Cancer Metastasis |
2000 (Cycle VI) |
$135,132 |
| Investigator(s): Jacqueline Testa , Ph.D. |
6IB-0012 |
| Targeting Breast Cancer Blood Vessels |
1999 (Cycle V) |
$363,905 |
| Investigator(s): Jan Schnitzer , M.D. |
5JB-0012 |
| Antibody-IL-2 Fusion Protein for Breast Cancer Immunotherapy |
1998 (Cycle IV) |
$419,144 |
| Investigator(s): Joseph Lustgarten , Ph.D. |
4KB-0010 |
| Enhancing breast cancer sensitivity to chemotherapy |
1997 (Cycle III) |
$380,825 |
| Investigator(s): Daniel Mercola , M.D., Ph.D. |
3CB-0246 |
| Hormonal Control of HER2neu and BRCA1 in Breast Cancer |
1997 (Cycle III) |
$286,676 |
| Investigator(s): Wanda Reynolds , Ph.D. |
3IB-0181 |
| Novel retinoids that induce apoptosis in breast cancer cells |
1996 (Cycle II) |
$377,091 |
| Investigator(s): Magnus Pfahl , Ph.D. |
2CB-0110 |
